Showing 761-770 of 1795 results for "".
Conjunctival Melanoma
https://crstoday.com/crst-issues/feb-2024/conjunctival-melanoma/45231/Diagnosing and treating this uncommon entity.New Corneal Imaging and Planning
https://crstoday.com/crst-issues/jan-2024/new-corneal-imaging-and-planning/45196/The latest innovations to increase the accuracy of preoperative anterior segment measurements.Intracameral Prophylaxis in Cataract Surgery
https://crstoday.com/topics/general/intracameral-prophylaxis-in-cataract-surgery/43060/Selecting an agent.Striving to Meet the Big Five Ocular Surface Challenges
https://crstoday.com/topics/cornea/striving-to-meet-the-big-five-ocular-surface-challenges/45218/What’s new in the management of ocular surface disease?Which Eye to Treat?
https://crstoday.com/topics/cataract-surgery/which-eye-to-treat/44094/A patient with a history of trauma presents a challenge.How Do You Open a Balloon Without Popping It?
https://crstoday.com/topics/cataract-surgery/how-do-you-open-a-balloon-without-popping-it/44592/A young patient with diabetes presents with bilateral intumescent white cataracts.Wavefront Aberrometry in Cataract Surgery and Laser Vision Correction
https://crstoday.com/topics/general/wavefront-aberrometry-in-cataract-surgery-and-laser-vision-correction/42204/Case Studies in Pupil Dilation
https://crstoday.com/topics/cataract-surgery/case-studies-in-pupil-dilation/44284/A variety of techniques and devices are available to facilitate cataract surgery in eyes with a small pupil.Optimizing Visual Performance with EDOF IOLs: Why Clareon Vivity is My Personal Choice
https://crstoday.com/crst-supplements-2/optimizing-visual-performance-with-edof-iols-why-clareon-vivity-is-my-personal-choice/optimizing-visual-performance-with-edof-iols-why-clareon-vivity-is-my-personal-choice/60857/Environmentally Sustainable Practices in the Eye Health Sector
https://crstoday.com/crst-issues/oct-2021/environmentally-sustainable-practices-in-the-eye-health-sector/44566/Efforts to improve ophthalmology’s carbon footprint.
